At a median 5-year (60.3 months) planned follow-up of the Phase 2b KEYNOTE-942/mRNA-4157-P201 study, intismeran ...
Emerging data suggest Western dietary patterns may promote inflammatory gut changes, whereas traditional diets appear linked to more favorable metabolic effects.
In a quest to provide more relevant translational data, traditional in vivo models join forces with new approach methodologies.
Moderna and Merck present 5-year data for intismeran autogene in combo with Keytruda in patients with high-risk stage III/IV melanoma following complete resection at 2026 ASCO mee ...
From unreliable narrators to collapsed timelines, these 25 films hide their real meaning in plain sight — and reveal it fully only on a second watch ...
I would like to welcome you to the Credicorp Ltd First quarter 2026 conference call. A slide presentation will accompany ...
Welcome to Aroa Biosurgery's Full Year FY '26 Results Presentation following the FY '26 audited financial results announcement released to the market this morning. [Operator Instructions] Please note ...
Five issued U.S. patents cover the combination of ImmunityBio’s IL-15 receptor agonist (NAI) with Bacillus Calmette-Guérin (BCG) for non-muscle invasive bladder cancer treatment, with terms extending ...
When India’s markets are going quantum, the country's most powerful exchange is still obsessed with filing just the Annual Compliance Reports (ACRs). Financial markets are no longer governed by human ...
Morning Overview on MSN
Customized mRNA vaccines built on each tumor’s genetic profile just pushed pancreatic cancer patients into remission — trial results carrying strongest signal yet for the ...
Sixteen patients with surgically removed pancreatic cancer received a vaccine that existed nowhere in the world until their own tumors were sequenced. For eight of them, the shot triggered an immune ...
Human clinical trials demonstrate that functionally targeted Omni-Biotic AB 10 prevents diarrhea, reduces C. difficile risk, ...
GMX users in the DACH region gain access to generative AI functions for writing and reading emails. Models are to run exclusively in Germany. GMX is bringing AI functions to its users' email inboxes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results